Rothschild Investment LLC’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.14M Buy
50,129
+36,272
+262% +$1.97M 0.08% 233
2026
Q1
$870K Buy
13,857
+9,380
+210% +$750K 0.05% 294
2025
Q4
$427K Sell
4,477
-261
-6% -$25.6K 0.02% 403
2025
Q3
$463K Buy
4,738
+167
+4% +$17.3K 0.03% 375
2025
Q2
$491K Sell
4,571
-22
-0.5% -$2.23K 0.03% 345
2025
Q1
$463K Buy
4,593
+200
+5% +$20.1K 0.03% 356
2024
Q4
$392K Buy
4,393
+80
+2% +$7.04K 0.03% 387
2024
Q3
$361K Sell
4,313
-45
-1% -$3.55K 0.02% 402
2024
Q2
$336K Buy
4,358
+646
+17% +$47.3K 0.02% 403
2024
Q1
$254K Buy
3,712
+220
+6% +$14.1K 0.02% 423
2023
Q4
$202K Buy
+3,492
New +$186K 0.02% 413
2021
Q3
Sell
-26,568
Closed -$1.14M 489
2021
Q2
$1.14M Buy
26,568
+248
+0.9% +$10.4K 0.09% 214
2021
Q1
$1.02M Sell
26,320
-265
-1% -$10K 0.09% 217
2020
Q4
$956K Buy
26,585
+451
+2% +$16.3K 0.09% 202
2020
Q3
$998K Buy
+26,134
New +$1.01M 0.11% 176

Other funds holding BSX

Rothschild Investment LLC's BSX Position: Q2 2026 in Review

Rothschild Investment LLC increased its Boston Scientific (BSX) stake by 262% in Q2 2026, buying an estimated $1.97M and bringing the position to 50,129 shares worth $2.14M. The position accounts for 0.08% of the portfolio, ranked #233.

Rothschild Investment LLC first reported a position in BSX in Q3 2020 and has held it in 15 quarters since. 712 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Rothschild Investment LLC held 50,129 shares of Boston Scientific worth $2.14M as of Q2 2026.
  • Rothschild Investment LLC bought 36,272 Boston Scientific shares in Q2 2026, an estimated $1.97M.
  • Boston Scientific made up 0.08% of Rothschild Investment LLC's portfolio in Q2 2026, its #233 holding.
  • Rothschild Investment LLC first reported a position in Boston Scientific in Q3 2020 and has held it in 15 quarters since.
  • 712 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.